ClinicalTrials.gov record
Not listed Phase 2 Interventional

Autologous Dendritic Cells Loaded With Autologous Tumor Associated Antigens for Treatment of Advanced Epithelial Ovarian Carcinomas

ClinicalTrials.gov ID: NCT02033616

Public ClinicalTrials.gov record NCT02033616. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 6, 2026, 2:07 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase II, Double-Blind, Randomized Trial Of AVOVA-1 (Autologous Dendritic Cells Loaded With Autologous Tumor Associated Antigens) Vs. Autologous Peripheral Blood Mononuclear Cells (MC) In Patients With Stage III Or IV Epithelial Ovarian, Fallopian Tube Or Primary Peritoneal Carcinoma After Primary Therapy

Study identification

NCT ID
NCT02033616
Recruitment status
Not listed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Aivita Biomedical, Inc.
Industry
Enrollment
99 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 17, 2017
Primary completion
Mar 14, 2022
Completion
Feb 28, 2023
Last update posted
Apr 24, 2022

2017 – 2023

United States locations

U.S. sites
6
U.S. states
2
U.S. cities
5
Facility City State ZIP Site status
Disney Family Cancer Center Burbank California 91505
Scripps Health La Jolla California 92037
UC San Diego, Moores Cancer Center La Jolla California 92093
Hoag Memorial Hospital Presbyterian Newport Beach California 92658
UC Irvine, Chao Family Comprehensive Cancer Center Orange California 92868
University of Colorado Hospital - Cancer Center Aurora Colorado 80045

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02033616, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 24, 2022 · Synced May 6, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02033616 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →